Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parasitic Diseases

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    August 2019
  1. PETT H, Bradley J, Okebe J, Dicko A, et al
    CYP2D6 polymorphisms and the safety and gametocytocidal activity of single dose primaquine for P. falciparum.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00538.
    PubMed     Text format     Abstract available


    July 2019
  2. ZHOU R, Yang C, Li S, Zhao Y, et al
    Molecular surveillance of drug resistance of Plasmodium falciparum isolates imported from Angola in Henan Province, China.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00552.
    PubMed     Text format     Abstract available


  3. CONRAD MD, Nsobya SL, Rosenthal PJ
    The diversity of the Plasmodium falciparum K13 propeller domain did not increase after implementation of artemisinin-based combination therapy in Uganda.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01234.
    PubMed     Text format     Abstract available


  4. EGUI A, Thomas MC, Fernandez-Villegas A, Perez-Anton E, et al
    A parasite biomarker set for evaluating benznidazole treatment efficacy in patients with chronic asymptomatic Trypanosoma cruzi infection.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.02436.
    PubMed     Text format     Abstract available


  5. CHAKRABARTI R, White J, Babar PH, Kumar S, et al
    Decreased in vitro artemisinin sensitivity of Plasmodium falciparum across India.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00101.
    PubMed     Text format     Abstract available


  6. WIJNANT GJ, Croft SL, de la Flor R, Alavijeh M, et al
    Pharmacokinetics and pharmacodynamics of the nitroimidazole DNDI-0690 in mouse models of cutaneous leishmaniasis.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00829.
    PubMed     Text format     Abstract available


    June 2019
  7. COLLETT CF, Kitson C, Baker N, Steele-Stallard HB, et al
    Chemogenomic profiling of anti-leishmanial efficacy and resistance in the related kinetoplastid parasite Trypanosoma brucei.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00795.
    PubMed     Text format     Abstract available


    May 2019
  8. PESSANHA DE CARVALHO L, Sandri TL, Jose Tenorio de Melo E, Fendel R, et al
    Ivermectin impairs the development of sexual and asexual stages of Plasmodium falciparum in vitro.
    Antimicrob Agents Chemother. 2019 May 20. pii: AAC.00085.
    PubMed     Text format     Abstract available


  9. PACHECO MA, Kadakia ER, Chaudhary Z, Perkins DJ, et al
    Evolution and genetic diversity of the k13 gene associated with artemisinin delayed parasite clearance in Plasmodium falciparum.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.02550.
    PubMed     Text format     Abstract available


    April 2019
  10. PALIC S, Bhairosing P, Beijnen JH, Dorlo TPC, et al
    Host-mediated activity of miltefosine in leishmaniasis through immunomodulation: a systematic review.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.02507.
    PubMed     Text format     Abstract available


  11. GRESTY K, Anderson K, Pasay C, Waters NC, et al
    Polymorphisms in P. falciparum Kelch13 and P. vivax Kelch12 genes in parasites collected from three South Pacific countries prior to extensive exposure to artemisinin combination therapies.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00536.
    PubMed     Text format     Abstract available


    March 2019
  12. COLLINS KA, Ruckle T, Elliott S, Marquart L, et al
    DSM265 400 mg clears asexual stage parasites but not mature gametocytes from the blood of healthy subjects experimentally infected with Plasmodium falciparum.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.01837.
    PubMed     Text format     Abstract available


  13. DE ARAUJO CB, de Lima LP, Calderano SG, Damasceno FS, et al
    Pep5, a fragment of cyclin D2, shows antiparasitic effects in different stages of the Trypanosoma cruzi life cycle and blocks parasite infectivity.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.01806.
    PubMed     Text format     Abstract available


    February 2019
  14. XU C, Sun H, Wei Q, Li J, et al
    Mutation profile of pfdhfr and pfdhps in Plasmodium falciparum among returned migrant workers in China from Africa.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.01927.
    PubMed     Text format     Abstract available


  15. MIRA-MARTINEZ S, Pickford AK, Rovira-Graells N, Guetens P, et al
    Identification of antimalarial compounds that require CLAG3 for their uptake by P. falciparum-infected erythrocytes.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.00052.
    PubMed     Text format     Abstract available


  16. DIAZ M, de Lucio H, Moreno E, Espuelas S, et al
    NOVEL UREA, THIOUREA AND SELENOUREA DERIVATIVES OF DISELENIDES: SYNTHESIS AND LEISHMANICIDAL ACTIVITY.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02200.
    PubMed     Text format     Abstract available


  17. TONG JX, Ang SEL, Tan EHN, Tan KSW, et al
    Viability Screen of LOPAC(1280) Reveals Tyrosine Kinase Inhibitor Tyrphostin A9 as a Novel Partner Drug for Artesunate Combinations to Target the Plasmodium falciparum Ring Stage.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02389.
    PubMed     Text format     Abstract available


    January 2019
  18. LEANG R, Mairet-Khedim M, Chea H, Huy R, et al
    Efficacy and safety of pyronaridine-artesunate plus single-dose primaquine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Cambodia.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02242.
    PubMed     Text format     Abstract available


    December 2018
  19. GILSON PR, Nguyen W, Poole WA, Teixeira JE, et al
    Evaluation of 4-amino 2-anilinoquinazolines against Plasmodium and other apicomplexan parasites in vitro and in a P. falciparum humanized NOD-scid IL2Rgamma(null) mouse model of malaria.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.01804.
    PubMed     Text format     Abstract available


    November 2018
  20. FERNANDEZ-RUBIO C, Larrea E, Pena Guerrero J, Sesma Herrero E, et al
    LEISHMANICIDAL ACTIVITY OF ISOSELENOCYANATE DERIVATIVES.
    Antimicrob Agents Chemother. 2018 Nov 26. pii: AAC.00904.
    PubMed     Text format     Abstract available


  21. BREGLIO KF, Rahman RS, Sa JM, Hott A, et al
    Correction for Breglio et al., "Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  22. BRUNSCHWIG C, Lawrence N, Taylor D, Abay E, et al
    Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    October 2018
  23. LIMA ML, Abengozar MA, Nacher-Vazquez M, Martinez-Alcazar MP, et al
    Drug repurposing for Leishmania. Molecular basis of the leishmanicidal activity of the antidepressant sertraline.
    Antimicrob Agents Chemother. 2018 Oct 8. pii: AAC.01928.
    PubMed     Text format     Abstract available


  24. DEEP DK, Singh R, Kulshrestha A, Wajid S, et al
    Lipase precursor like protein promotes miltefosine tolerance in Leishmania donovani by enhancing parasite infectivity and eliciting anti-inflammatory responses in host macrophages.
    Antimicrob Agents Chemother. 2018 Oct 8. pii: AAC.00666.
    PubMed     Text format     Abstract available


    September 2018
  25. LOZANO S, Gamallo P, Gonzalez-Cortes C, Presa Matilla JL, et al
    Gametocytes from K13-propeller mutant Plasmodium falciparum clinical isolates demonstrate reduced susceptibility to dihydroartemisinin in the male gamete exflagellation inhibition assay.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01426.
    PubMed     Text format     Abstract available


    August 2018
  26. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretrovira
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01162.
    PubMed     Text format     Abstract available


  27. DINI S, Zaloumis S, Cao P, Price RN, et al
    Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01068.
    PubMed     Text format     Abstract available


  28. SEBASTIAN-PEREZ V, Hendrickx S, Munday JC, Kalejaiye T, et al
    Cyclic nucleotide specific phosphodiesterases as potential drug targets for anti-Leishmania therapy.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.00603.
    PubMed     Text format     Abstract available


  29. WIJNANT GJ, Van Bocxlaer K, Fortes Francisco A, Yardley V, et al
    Local skin inflammation in cutaneous leishmaniasis as a source of variable pharmacokinetics and therapeutic efficacy of liposomal amphotericin B.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00631.
    PubMed     Text format     Abstract available


    July 2018
  30. RODRIGUES GOMES L, Lavigne A, Peterka CL, Brasil P, et al
    Absence of K13 Polymorphism in Plasmodium falciparum Parasites from Brazilian Endemic Areas.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00354.
    PubMed     Text format     Abstract available


  31. DAS JL, Rulisa S, de Vries PJ, Mens PF, et al
    Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated Plasmodium falciparum malaria.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00518.
    PubMed     Text format     Abstract available


  32. SOUSA-BATISTA AJ, Escrivani-Oliveira D, Falcao CAB, Philippon CIMDS, et al
    Broad spectrum and safety of oral treatment with a promising nitrosylated chalcone in murine leishmaniasis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00792.
    PubMed     Text format     Abstract available


    June 2018
  33. MANHAS R, Tandon S, Sen SS, Tiwari N, et al
    Leishmania parasites are inhibited by the benzoxaborole AN2690 targeting leucyl-tRNA synthetase.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00079.
    PubMed     Text format     Abstract available


  34. YAO Y, Wu K, Xu M, Yang Y, et al
    Surveillance of genetic variations associated with antimalarial resistance of Plasmodium falciparum from returned migrant workers in Wuhan, Central China.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.02387.
    PubMed     Text format     Abstract available


  35. BRUNSCHWIG C, Lawrence N, Taylor D, Abay E, et al
    UCT943, a next generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00012.
    PubMed     Text format     Abstract available


  36. KATO KC, de Morais-Teixeira E, Islam A, Leite MF, et al
    Efficacy of Meglumine Antimoniate under Low Polymerization State Orally Administrated in Murine Model of Visceral Leishmaniasis.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00539.
    PubMed     Text format     Abstract available


  37. SANTOS SOUZA S, L'Episcopia M, Severini C, Udhayakumar V, et al
    PET-PCR for Detection of Plasmodium falciparum Plasmepsin 2 Gene copy number.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00317.
    PubMed     Text format     Abstract available


  38. COERTZEN D, Reader J, van der Watt M, Nondaba SH, et al
    Artemisone and artemiside - potent pan-reactive antimalarial agents that also synergize redox imbalance in P. falciparum transmissible gametocyte stages.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.02214.
    PubMed     Text format     Abstract available


  39. MEYER KJ, Caton E, Shapiro TA
    Model system identifies kinetic driver of Hsp90 inhibitor activity against African trypanosomes and Plasmodium falciparum.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00056.
    PubMed     Text format     Abstract available


  40. KOVAC J, Meister I, Neodo A, Panic G, et al
    Pharmacokinetics of praziquantel in Schistosoma mansoni and Schistosoma haematobium infected school- and preschool- aged children.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.02253.
    PubMed     Text format     Abstract available


    May 2018
  41. YAN HB, Smout MJ, Ju C, Folley AE, et al
    Developmental sensitivity in Schistosoma mansoni to puromycin to establish drug selection of transgenic schistosomes.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.02568.
    PubMed     Text format     Abstract available


    March 2018
  42. DEMBELE L, Gupta DK, Lim MY, Ang X, et al
    Imidazolopiperazines (IPZ) kill both rings and dormant rings in wild type and K13 artemisinin resistant Plasmodium falciparum in vitro.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02235.
    PubMed     Text format     Abstract available


  43. VAN BOCXLAER K, Gaukel E, Hauser D, Park SH, et al
    Topical treatment for cutaneous leishmaniasis - dermato-pharmacokinetic led optimisation of benzoxaboroles.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.02419.
    PubMed     Text format     Abstract available


    February 2018
  44. ARMITAGE EG, Alqaisi AQI, Godzien J, Pena I, et al
    A complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02095.
    PubMed     Text format     Abstract available


  45. BREGLIO KF, Rahman RS, Sa JM, Roberts DJ, et al
    Kelch mutations in Plasmodium falciparum protein K13 do not modulate dormancy after artemisinin exposure and sorbitol selection in vitro.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02256.
    PubMed     Text format     Abstract available


  46. MUKHERJEE A, Gagnon D, Wirth DF, Richard D, et al
    Inactivation of Plasmepsin 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02309.
    PubMed     Text format     Abstract available


    January 2018
  47. KOBASA T, Talundzic E, Sug-Aram R, Boondat P, et al
    The emergence and spread of kelch 13 mutations associated with artemisinin resistance in Plasmodium falciparum parasites in twelve Thai provinces from 2007 - 2016.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02141.
    PubMed     Text format     Abstract available


  48. DUVALSAINT M, Kyle DE
    Phytohormones, isoprenoids and role of the apicoplast in recovery from dihydroartemisinin-induced dormancy of Plasmodium falciparum.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01771.
    PubMed     Text format     Abstract available


  49. TONG JX, Chandramohanadas R, Tan KS
    High-Content Screening of MMV Pathogen Box for Plasmodium falciparum Digestive Vacuole Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02031.
    PubMed     Text format     Abstract available


  50. HARRIS LM, Monsell KR, Noulin F, Famodimu MT, et al
    G-quadruplex DNA motifs in the malaria parasite Plasmodium falciparum and their potential as novel antimalarial drug targets.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01828.
    PubMed     Text format     Abstract available


    December 2017
  51. WIJNANT GJ, Van Bocxlaer K, Yardley V, Harris A, et al
    AmBisome(R) treatment of murine cutaneous leishmaniasis: relation between skin pharmacokinetics and efficacy.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02009.
    PubMed     Text format     Abstract available


  52. DE JESUS SOUSA-BATISTA A, Pacienza-Lima W, Arruda-Costa N, Falcao CAB, et al
    Depot subcutaneous injection with chalcone CH8-loaded PLGA microspheres aiming at a single-dose treatment of cutaneous leishmaniasis.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01822.
    PubMed     Text format     Abstract available


  53. MALVY D, Torrentino-Madamet M, L'Ollivier C, Receveur MC, et al
    Plasmodium falciparum Recrudescence Two Years after a First Treated Uncomplicated Infection without Return in a Malaria Endemic Area.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.01892.
    PubMed     Text format     Abstract available


    November 2017
  54. BHALLA P, Sultana S, Chiranjivi AK, Saikia AK, et al
    Synthesis of Methyl 4-(7-hydroxy-4,4,8-trimethyl-3-oxabicyclo[3.3.1]nonan-2-yl)benzoate and their evaluation as anti-leishmanial: Synergistic effect with Miltefosine.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01810.
    PubMed     Text format     Abstract available


  55. UDDIN T, McFadden GI, Goodman CD
    Validation of putative apicoplast targeting drugs using a chemical supplementation assay in cultured human malaria parasites.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01161.
    PubMed     Text format     Abstract available


    October 2017
  56. KONG D, Zhou C, Guo H, Wang W, et al
    Praziquantel targets M1 macrophages and ameliorates splenomegaly in chronic schistosomiasis.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.00005.
    PubMed     Text format     Abstract available


  57. DAS S, Giri S, Sundar S, Shaha C, et al
    Leishmania donovani Tryparedoxin Peroxidases: functional involvement during infection and drug treatment.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.00806.
    PubMed     Text format     Abstract available


  58. GARGANO N, Madrid L, Valentini G, D'Alessandro U, et al
    A new water-dispersible paediatric formulation of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in African infants: efficacy and tolerability outcomes of a phase II, randomized, open label, multicenter
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.00596.
    PubMed     Text format     Abstract available


  59. PINTO-MARTINEZ AK, Rodriguez-Duran J, Serrano-Martin X, Hernandez-Rodriguez V, et al
    Mechanism of action of miltefosine on Leishmania donovani involves the impairment of acidocalcisomes function and the activation of the sphingosine-dependent plasma membrane Ca2+ channel.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01614.
    PubMed     Text format     Abstract available


  60. CAO P, Klonis N, Zaloumis S, Dogovski C, et al
    A dynamic stress model explains the delayed drug effect in artemisinin treatment of Plasmodium falciparum.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.00618.
    PubMed     Text format     Abstract available


  61. ARCARI T, Manzano JI, Gamarro F
    ABCI3, a new mitochondrial ABC transporter from Leishmania major involved in susceptibility to antimonials and infectivity.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01115.
    PubMed     Text format     Abstract available


  62. PANIC G, Ruf MT, Keiser J
    Immunohistochemical investigations of treatment with Ro 13-3978, praziquantel, oxamniquine and mefloquine in Schistosoma mansoni-infected mice.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01142.
    PubMed     Text format     Abstract available


  63. AMAMBUA-NGWA A, Okebe J, Mbye H, Ceesay S, et al
    Sustained ex vivo susceptibility of Plasmodium falciparum to artemisinin derivatives but increasing tolerance to ACT partner quinolines in The Gambia.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.00759.
    PubMed     Text format     Abstract available


    September 2017
  64. MONTENEGRO M, Neal AT, Posada M, De Las Salas B, et al
    K13-propeller Alleles, Mdr1 Polymorphism, and Drug Effectiveness at Day 3 after Artemether-lumefantrine Treatment for Plasmodium falciparum Malaria in Colombia, 2014-2015.
    Antimicrob Agents Chemother. 2017 Sep 25. pii: AAC.01036.
    PubMed     Text format     Abstract available


  65. BOYLE MJ, Skidmore M, Dickerman B, Cooper L, et al
    Identification of heparin modifications and polysaccharide inhibitors of Plasmodium falciparum merozoite invasion that have potential for novel drug development.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00709.
    PubMed     Text format     Abstract available


    June 2017
  66. VOAK AA, Harris A, Qaiser Z, Croft SL, et al
    Treatment of experimental visceral leishmaniasis with single-dose liposomal amphotericin B - pharmacodynamics and biodistribution at different stages of disease.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00497.
    PubMed     Text format     Abstract available


  67. IMAN M, Huang Z, Alavizadeh SH, Szoka FC Jr, et al
    Study of Biodistribution and in vivo Anti-leishmanial Activity of a Distigmasterylhemisuccinoyl-glycero-phosphocholine Liposome-intercalated Amphotericin B.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.02525.
    PubMed     Text format     Abstract available


  68. WIJNANT GJ, Van Bocxlaer K, Yardley V, Murdan S, et al
    Efficacy of a Paromomycin plus Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00358.
    PubMed     Text format     Abstract available


  69. BLAKE LD, Johnson ME, Siegel SV, McQueen A, et al
    Menoctone resistance in malaria parasites is conferred by M133I mutations in cytochrome b that are transmissible through mosquitos.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00689.
    PubMed     Text format     Abstract available


    May 2017
  70. WIRJANATA G, Handayuni I, Prayoga P, Leonardo L, et al
    Plasmodium falciparum and P. vivax demonstrate contrasting chloroquine resistance reversal phenotypes.
    Antimicrob Agents Chemother. 2017 May 22. pii: AAC.00355.
    PubMed     Text format     Abstract available


  71. VELASQUEZ AMA, Ribeiro WC, Venn V, Castelli S, et al
    Efficacy of a Binuclear Cyclopalladated Compound Therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on Topoisomerase 1B.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00688.
    PubMed     Text format     Abstract available


  72. TELLEZ J, Romero I, Soares MJ, Steindel M, et al
    KNOCKDOWN OF HOST ANTIOXIDANT DEFENSE GENES ENHANCES THE EFFECT OF GLUCANTIME ON INTRACELLULAR Leishmania braziliensis IN HUMAN MACROPHAGES.
    Antimicrob Agents Chemother. 2017 May 1. pii: AAC.02099.
    PubMed     Text format     Abstract available


    April 2017
  73. CHENET SM, Akinyi Okoth S, Kelley J, Lucchi N, et al
    Molecular profile of malaria drug resistance markers of Plasmodium falciparum in Suriname.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.02655.
    PubMed     Text format     Abstract available


    March 2017
  74. MOREIRA VR, de Jesus LC, Soares RP, Silva LD, et al
    Glucantime(R) causes oxidative stress-derived DNA damage in Balb/c mice infected by Leishmania (Leishmania) infantum.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.02360.
    PubMed     Text format     Abstract available


  75. MARTIN-MONTES A, Plano D, Martin-Escolano R, Alcolea V, et al
    A library of seleno-compounds and Leishmania species: Rising evidences towards novel agents.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.02546.
    PubMed     Text format     Abstract available


  76. TALUNDZIC E, Ndiaye YD, Deme AB, Olsen C, et al
    Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    February 2017
  77. SZAJNMAN SH, Galaka T, Li ZH, Li C, et al
    In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: